Literature DB >> 9548806

Dialkylquinonimines validated as in vivo metabolites of alachlor, acetochlor, and metolachlor herbicides in rats.

P R Jefferies1, G B Quistad, J E Casida.   

Abstract

The oncogenicity of chloroacetanilide herbicides (1-5) is proposed to involve bioactivation to 2,6-dialkylbenzoquinonimines (quinonimines, 9) based on two earlier observations: (1) in vitro conversion of the alachlor (1) metabolite diethylaniline (7Et2) to 2, 6-diethylquinonimine (9Et2) which reacts readily with GSH and (2) induction of sister chromatid exchanges in human lymphocytes for the parent herbicides and their purported 9 metabolites. This hypothesis lacks in vivo evidence for 9 formation which might be provided by analysis of urine and tissue for thiol adducts of 9. Accordingly, two mercapturates (10Et2 and 10Me2) and a cysteine conjugate (11Me2) were prepared by addition of N-acetylcysteine or cysteine to 9Et2 and the 2,6-dimethyl homologue (9Me2). Mercapturate 10Et2 was characterized by HPLC using the urine of rats treated ip with hydroxyaniline 8Et2, and both mercapturate 10Me2 and cysteine conjugate 11Me2 were found in the urine of mice administered hydroxyaniline 8Me2. The mercapturates were then converted to the N, N-dimethyl-2,6-dialkyl-4-methoxy-3-(methylthio)anilines (12Et2, 12EtMe, and 12Me2) by alkaline permethylation, thereby providing a method for analysis of 9-derived thiol adducts in urine and liver as the 12 derivatives by GC/MS with selected ion monitoring. The urine of rats 0-6 h after ip treatment with 1, butachlor (2), acetochlor (3), metolachlor (4), and dimethachlor (5) at 0.74 mmol/kg yields permethylated derivatives which are definitively diagnostic for the 9 intermediates from each of the herbicides in amounts of 3-24-fold above the minimum detectable limit, as well as 1 and 2 orders of magnitude higher from the corresponding anilines (7) and hydroxyanilines (8), respectively. Similar liver analyses reveal tissue thiol adducts of 9 6 h after treatment with 7 and 8 but not with the parent herbicides. The yields of urinary 9 derivatives from the parent herbicides are higher from the 2,6-diethyl series (1 and 2) and the 2-ethyl-6-methyl derivatives (3 and 4) than from the 2, 6-dimethyl analogue (5). These findings provide direct evidence in vivo that quinonimines are metabolites of 1-5 in rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548806     DOI: 10.1021/tx970209z

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  5 in total

1.  Retrospective mining of toxicology data to discover multispecies and chemical class effects: Anemia as a case study.

Authors:  Richard S Judson; Matthew T Martin; Grace Patlewicz; Charles E Wood
Journal:  Regul Toxicol Pharmacol       Date:  2017-02-24       Impact factor: 3.271

2.  Hydroxyphenylation of Histone Lysines: Post-translational Modification by Quinone Imines.

Authors:  Kodihalli C Ravindra; Laura J Trudel; John S Wishnok; Gerald N Wogan; Steven R Tannenbaum; Paul L Skipper
Journal:  ACS Chem Biol       Date:  2016-02-18       Impact factor: 5.100

3.  Genotoxicity of 2,6- and 3,5-dimethylaniline in cultured mammalian cells: the role of reactive oxygen species.

Authors:  Ming-Wei Chao; Min Young Kim; Wenjie Ye; Jing Ge; Laura J Trudel; Crystal L Belanger; Paul L Skipper; Bevin P Engelward; Steven R Tannenbaum; Gerald N Wogan
Journal:  Toxicol Sci       Date:  2012-07-24       Impact factor: 4.849

4.  Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes.

Authors:  S Coleman; R Linderman; E Hodgson; R L Rose
Journal:  Environ Health Perspect       Date:  2000-12       Impact factor: 9.031

5.  Transimination of quinone imines: a mechanism for embedding exogenous redox activity into the nucleosome.

Authors:  Wenjie Ye; Uthpala I Seneviratne; Ming-Wei Chao; Kodihalli C Ravindra; Gerald N Wogan; Steven R Tannenbaum; Paul L Skipper
Journal:  Chem Res Toxicol       Date:  2012-12-03       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.